THE ENDOMETRIOSIScrisis
MILLIONS OF WOMEN ENDURE YEARS OF PAIN BEFORE RECEIVING A DIAGNOSIS
THE CHALLENGE
A DIAGNOSTIC SYSTEM THAT'S failing PATIENTS
ENDOMETRIOSIS AFFECTS APPROXIMATELY 1.5 MILLION WOMEN IN THE UK ALONE. DESPITE ITS PREVALENCE, THE CONDITION REMAINS CHRONICALLY UNDERDIAGNOSED.
THE CURRENT DIAGNOSTIC GOLD STANDARD — LAPAROSCOPIC SURGERY — IS INVASIVE, EXPENSIVE, AND DIFFICULT TO ACCESS. SYMPTOMS ARE FREQUENTLY DISMISSED OR MISATTRIBUTED. THE RESULT IS YEARS OF UNNECESSARY SUFFERING, REDUCED QUALITY OF LIFE, AND IN MANY CASES, PREVENTABLE DISEASE PROGRESSION.
8–12 YRS
AVERAGE DIAGNOSTIC DELAY GLOBALLY
1.5M
WOMEN AFFECTED IN THE UK
£8.2BN
ESTIMATED ANNUAL COST TO THE UK ECONOMY
TWO PATHWAYS COMPARED
THE CURRENT ROUTE VS. THE Endoscan ROUTE
TRADITIONAL PATHWAY
SYMPTOMS DISMISSED BY GP
MULTIPLE GP VISITS AND REFERRALS
NHS GYNAECOLOGY WAITING LIST
STANDARD ULTRASOUND (OFTEN INCONCLUSIVE)
FURTHER REFERRAL FOR LAPAROSCOPY
SURGICAL WAITING LIST
INVASIVE DIAGNOSTIC SURGERY
TYPICAL DURATION: 4–12 YEARS
ENDOSCAN PATHWAY
SELF-REFERRAL OR GP/CLINICIAN REFERRAL
SPECIALIST ENDOMETRIOSIS ULTRASOUND
EXPERT REVIEW BY A CONSULTANT GYNAECOLOGIST
SAME-DAY CLINICAL REPORT
INFORMED TREATMENT DECISIONS
TYPICAL DURATION: 1 APPOINTMENT